Stefan C. Linn (Managing Partner & CEO L1 Health)
Stefan Linn is Managing Partner and CEO of L1 Health since 2020. Prior to joining LetterOne, Stefan was Chief Operating Officer of Oxford Immunotec, a NASDAQ-traded diagnostics company focused on immune-related conditions, and responsible for global commercial operations, manufacturing, supply chain, and product development.
Before joining Oxford Immunotec, Stefan was a member of the senior executive team at IMS Health (now IQVIA) in a variety of roles to advance the company’s transformation following its take private by TPG, including strategy, acquisitions, commercial operations, and global product development. Stefan joined IMS Health from TPG Capital, a leading private investment firm, where he evaluated the operating potential of new investments and worked with TPG’s operating companies to drive operating improvements. Previous to that, Stefan held senior positions at McKesson Corporation, responsible for marketing and product development, as well as its direct-to-patient business McKesson Patient Relationship Solutions, the packaging operation RxPack and the pharmacy franchise Health Mart. Earlier in his career, Stefan worked at Merck-Medco and was a founding executive of its Systemed division. He also worked for McKinsey & Company in Europe and the U.S.
Stefan earned his bachelor’s degree in Economics from the University of Dallas and his Master of Business Administration from the University of California at Berkeley.